Sp187
EXPLORING NOVEL COMPOUNDS THAT SHAPE THE GUT MICROBIOTA
Date
May 18, 2024
Presenter
Cedars-Sinai Medical Center Inflammatory Bowel Disease Center
Tracks
Related Products
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
Engineered Probiotics- Latest Advances & Future Outlook
This session will focus on the latest advances and future outlook of engineered probiotics, highlighting how they differ from existing probiotics. Attendees will learn about the newest approaches to improving probiotics and review pre-clinical data using engineered probiotics…
